David Miles Meredith, M.D.,Ph.D.
This page shows the publications David Meredith has written about Protein Kinase Inhibitors.
Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavity. BMJ Case Rep. 2018 Apr 11; 2018.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.